These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27306066)

  • 21. Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn's Disease: On the Way to Personalized Medicine?
    Hoffmann P; Lamerz D; Hill P; Kirchner M; Gauss A
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34198814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease.
    Rufini S; Ciccacci C; Di Fusco D; Ruffa A; Pallone F; Novelli G; Biancone L; Borgiani P
    Dig Liver Dis; 2015 Sep; 47(9):744-50. PubMed ID: 26066377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
    Weersma RK; Stokkers PC; Cleynen I; Wolfkamp SC; Henckaerts L; Schreiber S; Dijkstra G; Franke A; Nolte IM; Rutgeerts P; Wijmenga C; Vermeire S
    Am J Gastroenterol; 2009 Mar; 104(3):630-8. PubMed ID: 19174780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotype in orofacial granulomatosis with and without Crohn's disease.
    Gale G; Ostman S; Saalman R; Telemo E; Jontell M; Hasséus B
    Med Oral Patol Oral Cir Bucal; 2014 Nov; 19(6):e584-591. PubMed ID: 25350593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.
    Salkic NN; Adler G; Zawada I; Alibegovic E; Karakiewicz B; Kozlowska-Wiechowska A; Wasilewicz M; Sulzyc-Bielicka V; Bielicki D
    Bosn J Basic Med Sci; 2015 May; 15(2):67-72. PubMed ID: 26042516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort.
    Wagner J; Sim WH; Ellis JA; Ong EK; Catto-Smith AG; Cameron DJ; Bishop RF; Kirkwood CD
    PLoS One; 2010 Nov; 5(11):e15376. PubMed ID: 21079743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
    Schnitzler F; Friedrich M; Wolf C; Stallhofer J; Angelberger M; Diegelmann J; Olszak T; Tillack C; Beigel F; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2015; 10(7):e0116044. PubMed ID: 26147989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.
    Jürgens M; Brand S; Laubender RP; Seiderer J; Glas J; Wetzke M; Wagner J; Pfennig S; Tillack C; Beigel F; Weidinger M; Schnitzler F; Kreis ME; Göke B; Lohse P; Herrmann K; Ochsenkühn T
    J Gastroenterol; 2010 Jul; 45(7):721-31. PubMed ID: 20428899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATG16L1 and IL23R variants and genetic susceptibility to crohn's disease: mode of inheritance based on meta-analysis of genetic association studies.
    Grigoras CA; Ziakas PD; Jayamani E; Mylonakis E
    Inflamm Bowel Dis; 2015 Apr; 21(4):768-76. PubMed ID: 25738374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orofacial granulomatosis--a 20-year review.
    Grave B; McCullough M; Wiesenfeld D
    Oral Dis; 2009 Jan; 15(1):46-51. PubMed ID: 19076470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azathioprine is effective for oral involvement in Crohn's disease but not for orofacial granulomatosis alone.
    Mentzer A; Goel R; Elliott T; Campbell H; Hullah E; Patel P; Challacombe S; Escudier M; Sanderson JD
    J Oral Pathol Med; 2016 Apr; 45(4):312-8. PubMed ID: 26593695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of IL23R and ATG16L1 with susceptibility of Crohn's disease in Chinese population.
    Zhang J; Chen J; Gu J; Guo H; Chen W
    Scand J Gastroenterol; 2014 Oct; 49(10):1201-6. PubMed ID: 25048429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of genetic profiles of Crohn's disease: a focus on the ATG16L1 gene.
    Grant SF; Baldassano RN; Hakonarson H
    Expert Rev Mol Diagn; 2008 Mar; 8(2):199-207. PubMed ID: 18366306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis.
    Homer CR; Richmond AL; Rebert NA; Achkar JP; McDonald C
    Gastroenterology; 2010 Nov; 139(5):1630-41, 1641.e1-2. PubMed ID: 20637199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOD2/CARD15 disease associations other than Crohn's disease.
    Henckaerts L; Vermeire S
    Inflamm Bowel Dis; 2007 Feb; 13(2):235-41. PubMed ID: 17206682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.